Ricerca Biosciences Releases Foresight Similarity Analysis Service
Ricerca Biosciences
, a preclinical contract research organization providing services to the biopharmaceutical industry, has announced its similarity analysis service, Foresight™.
Foresight allows compound assay results to be compared against the assay results of a large reference set of pharmacologically active compounds. The tool helps predict
in vivo
effects from
in vitro
pharmacology data and provides insight into additional, non-obvious compound activities.
The analysis service allows scientists to discover clues to the possibilities of a compound. Foresight can be used to direct compound modification to avoid adverse effects and determine new indications for safe or novel compounds.
Ricerca has previous worked with clients to profile compounds in the discovery space. With the development of this tool, Ricerca can now offer interpretation and predictive analysis of pharmacological data.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
